Major US health systems expect to offer Alzheimer's drug Leqembi in a few months
By Julie Steenhuysen and Deena Beasley CHICAGO Five major U.S. health systems said they would offer Eisai and
2023-08-07 18:26
US announces trial payment program for care providers of dementia patients
The U.S. government said on Monday it would trial a new payment program for people who provide dementia
2023-07-31 21:57
Promising new Alzheimer's drugs may benefit whites more than Blacks
By Julie Steenhuysen NEW YORK Groundbreaking treatments for Alzheimer's disease that work by removing a toxic protein called
2023-07-31 17:28
Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial
By Deena Beasley (Reuters) -Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in the
2023-07-17 22:15
Alzheimer's diagnosis revamp embraces rating scale similar to cancer
By Julie Steenhuysen Alzheimer's disease experts are revamping the way doctors diagnose patients with the progressive brain disorder
2023-07-16 22:15
Acumen's Alzheimer's drug passes initial safety test
By Julie Steenhuysen CHICAGO An experimental Alzheimer's disease drug developed by Acumen Pharmaceuticals targeting a novel form of
2023-07-16 15:15
Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug
Eisai Co Ltd and Biogen Inc's Leqembi emerged as the first Alzheimer's treatment to win the U.S. Food
2023-07-08 02:21
Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?
By Deena Beasley The U.S. Food and Drug Administration on Thursday granted standard approval to Eisai and Biogen's Leqembi for
2023-07-07 05:51
US FDA grants standard approval of Eisai/Biogen Alzheimer's drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -The U.S. Food and Drug Administration on Thursday granted standard approval
2023-07-07 05:29
Medicare offers details on reimbursement for new Alzheimer's drugs
By Julie Steenhuysen CHICAGO (Reuters) -The U.S. Medicare health plan on Thursday offered details of plans to collect patient data
2023-06-23 07:15
US FDA panel back traditional approval for Eisai-Biogen's Alzheimer's drug Leqembi
By Leroy Leo and Julie Steenhuysen A panel of expert advisers on Friday unanimously agreed that a late-stage
2023-06-10 04:16
Medicare will require data on patient use for approved Alzheimer's drugs
The Medicare health plan will cover new Alzheimer's drugs after full U.S. approval for patients who participate in
2023-06-01 23:27